You are here: Industry Insights > personalized

News List

Elios Announces Positive Top-Line Data Evaluating Personalized Therapeutic Cancer Vaccine americanpharmaceuticalreview
July 18, 2019
Elios Therapeutics announced positive top-line results from the Company's prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating its lead immuno-oncology candidate, the TLPLDC (tumor lysate ...
Personalizing precision medicine with combination therapies improves outcomes in cancer worldpharmanews
April 24, 2019
Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.
Redesigned CAR-T eliminates dangerous cytokine release syndrome in lymphoma trial fiercebiotech
April 23, 2019
Personalized CAR-T treatments for leukemia and lymphoma have offered new hope for patients with tough-to-treat disease, but the engineered cell therapies can cause a dangerous immune reaction called cytokine release syndrome (CRS).
Autolus taps Vineti to help deliver personalized cell therapies fiercebiotech
February 26, 2019
Autolus has a lot of CAR-T candidates heading for clinical trials and has teamed up with software company Vineti to try to bring them to market more efficiently....
Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies pharmafocusasia
January 08, 2019
Adaptive Biotechnologies, an immune-driven medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech....
FM, Roche, DIAN collaborate for Personalized Cancer Care in China biospectrumasia
April 28, 2018
DIAN is one of the leading independent medical laboratories in China and is dedicated to innovation in diagnostic testing platforms.
Europe's biggest private biotech company raises $270 million biospectrumasia
April 04, 2018
Europe's biggest private biotech company raises $270 million BioNTech has already signed a $310 million deal with Roche